Critical illnesses have a significant impact on overall survival among patients with cancer
the ONA take:
A new study from researchers at the University of Glasgow found 1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis, and a quarter of them died in hospital. In addition, this risk increased with age.
Using cancer registry and hospital data from Scotland spanning 10 years, the researchers captured information on more than 118,500 people with cancer, including 6,116 who were admitted to ICU.
Study findings showed that risk of ICU admission was highest among patients with GI cancer and lowest in patients with prostate cancer, breast cancer, and melanoma of the skin.
Mortality was higher among emergency medical admissions, and those who received organ support compared with those who did not receive organ support.
Deaths during hospital stays was higher among patients with cancers of unknown primary cause, lung cancer, and liver cancer, but those with head and neck cancers, multiple cancers, kidney cancer, and thyroid cancer had lower mortality rates.
The study indicates that critical illness may play a role in overall cancer outcomes. The researchers suggest that if ICUs can effectively reduce the risk of dying following a critical illness, increased surveillance for early signs of critical illness and access to ICU care for patients with cancer may improve overall survival rates.
1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|